1 – 5 of 34
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis
(
- Contribution to journal › Article
- 2023
-
Mark
The Effects of Different Management Strategies or Rehabilitation Approaches on Knee Joint Structural and Molecular Biomarkers Following Traumatic Knee Injury : A Systematic Review of Randomized Controlled Trials for the OPTIKNEE Consensus
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS-5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip
(
- Contribution to journal › Article
-
Mark
The alarmins high mobility group box protein 1 and S100A8/A9 display different inflammatory profiles after acute knee injury
(
- Contribution to journal › Article
-
Mark
Biological variation of human aggrecan ARGS neoepitope in synovial fluid and serum in early-stage knee osteoarthritis and after knee injury
(
- Contribution to journal › Article